Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage

Por Hui, Marco K. C., Chan, Kwok Wah, Luk, John M., Lee, Nikki P., Chung, Yvonne, Cheung, Leo C. M., Srivastava, Gopesh, Tsao, Sai Wah, Tang, Johnny C., Law, Simon
Publicado em 2011

In vitro antibacterial activity of a new 1-oxa cephalosporin compound.

Por Downs, J. T., Andriole, V. T.
Publicado em 1980

The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound

Por Escaich, S., Prouvensier, L., Saccomani, M., Durant, L., Oxoby, M., Gerusz, V., Moreau, F., Vongsouthi, V., Maher, Kirsty, Morrissey, Ian, Soulama-Mouze, C.
Publicado em 2011

A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1

Por Yanan Li, Ying Cheng, Maoqi Zhang, Xiaoli He, Li Kong, Kexiang Zhou, Yunfu Zhou, Lin Li, Hongqi Tian, Xiaomin Song, Yukun Cui
Publicado em 2020-07-01

I. A New Method of Direct Fixation of the Fragments in Compound and Ununited Fractures

Por Senn, Nicholas
Publicado em 1893

A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1

Por Li, Yanan, Cheng, Ying, Zhang, Maoqi, He, Xiaoli, Kong, Li, Zhou, Kexiang, Zhou, Yunfu, Li, Lin, Tian, Hongqi, Song, Xiaomin, Cui, Yukun
Publicado no iScience (2020)

Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection

Por St-Pierre, Christian, Ouellet, Michel, Giguère, Denis, Ohtake, Reiko, Roy, René, Sato, Sachiko, Tremblay, Michel J.
Publicado em 2012

Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA‐dependent apoptosis in colorectal cancer

Por Chen, Jingfei, Zhong, Juchang, Liu, Yeying, Huang, Yuan, Luo, Fei, Zhou, Yingjun, Pan, Xi, Cao, Shousong, Zhang, Lingling, Zhang, Yingjie, Wang, Jiangang
Publicado no Cancer Med (2018)

A Linear Combination of Pharmacophore Hypotheses as a New Tool in Search of New Active Compounds – An Application for 5-HT(1A) Receptor Ligands

Por Warszycki, Dawid, Mordalski, Stefan, Kristiansen, Kurt, Kafel, Rafał, Sylte, Ingebrigt, Chilmonczyk, Zdzisław, Bojarski, Andrzej J.
Publicado em 2013

Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors

Por Liu, Tong-chao, Peng, Xia, Ma, Yu-chi, Ji, Yin-chun, Chen, Dan-qi, Zheng, Ming-yue, Zhao, Dong-mei, Cheng, Mao-sheng, Geng, Mei-yu, Shen, Jing-kang, Ai, Jing, Xiong, Bing
Publicado no Acta Pharmacol Sin (2016)

Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam Compounds

Por Neu, Harold C., Aswapokee, Nalinee, Fu, Kwung P., Aswapokee, Prasit
Publicado em 1979

Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam Compounds

Publicado em 1979

Synthesis, Structure and Antitumour Properties of a New 1,2-Propylenediaminetetraacetate-Ruthenium(III) Compound

Por Vilaplana, R., Romero, M. A., Quirós, M., Salas, J. M., González-Vílchez, F.
Publicado em 1995

The natural products beauveriolide I and III: a new class of β-amyloid lowering compounds

Por Witter, Daniel P., Chen, Yanping, Rogel, Joseph K., Boldt, Grant E., Wentworth, Paul
Publicado em 2009

New Compounds from the Roots of Corsican <i>Calicotome Villosa</i> (Poir.) Link.: Two Pterocarpans and a Dihydrobenzofuran

Por Doreen Stacy Palu, Mathieu Paoli, Hervé Casabianca, Joseph Casanova, Ange Bighelli
Publicado em 2020-07-01

A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan

Por Kim, Jihee, Lana, Beatrice, Torelli, Silvia, Ryan, David, Catapano, Francesco, Ala, Pierpaolo, Luft, Christin, Stevens, Elizabeth, Konstantinidis, Evangelos, Louzada, Sandra, Fu, Beiyuan, Paredes‐Redondo, Amaia, Chan, AW Edith, Yang, Fengtang, Stemple, Derek L, Liu, Pentao, Ketteler, Robin, Selwood, David L, Muntoni, Francesco, Lin, Yung‐Yao
Publicado no EMBO Rep (2019)

RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compound.

Por Ash, R J, Parker, R A, Hagan, A C, Mayer, G D
Publicado em 1979

PA01.08. An evaluation of a new anti-aids herbo-mineral compound (laa-1)

Por Shukla, Pushpendra, Sharma, Vinamra, Singh, Vandana, Asthana, Aditi, Tiwari, S P, Srivastava, Ashok, Saxena, R C, Trivedi, V. P.
Publicado em 2012

Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds

Por Ziegler, Yvonne, Laws, Mary J., Sanabria Guillen, Valeria, Kim, Sung Hoon, Dey, Parama, Smith, Brandi P., Gong, Ping, Bindman, Noah, Zhao, Yuechao, Carlson, Kathryn, Yasuda, Mayuri A., Singh, Divya, Li, Zhong, El-Ashry, Dorraya, Madak-Erdogan, Zeynep, Katzenellenbogen, John A., Katzenellenbogen, Benita S.
Publicado no NPJ Breast Cancer (2019)

Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents

Por Luo, Zonghua, Rosenberg, Adam J., Liu, Hui, Han, Junbin, Tu, Zhude
Publicado no Eur J Med Chem (2018)